![Bengt Ågerup](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bengt Ågerup
Founder at Nexttobe AB
Net worth: 9 M $ as of 2024-06-29
Profile
Bengt Ågerup is the founder of Nexttobe AB and Q-Med AB.
He currently serves as a Director at Ixion Biotechnology, Inc. Dr. Ågerup has formerly served as Chairman at Moleculink AB and Director at Envirotainer AB.
He holds a doctorate degree from the University of Uppsala, which he received in 1974.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
HANSA BIOPHARMA AB
3.18% | 2023-12-30 | 2,155,379 ( 3.18% ) | 9 M $ | 2024-06-29 |
Bengt Ågerup active positions
Companies | Position | Start |
---|---|---|
Ixion Biotechnology, Inc.
![]() Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL. | Director/Board Member | - |
Nexttobe AB
![]() Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Founder | - |
Former positions of Bengt Ågerup
Companies | Position | End |
---|---|---|
Q-Med AB
![]() Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Founder | - |
Moleculink AB
![]() Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Chairman | - |
Envirotainer AB
![]() Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Director/Board Member | - |
Training of Bengt Ågerup
University of Uppsala | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Ixion Biotechnology, Inc.
![]() Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL. | Health Technology |
Envirotainer AB
![]() Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Process Industries |
Q-Med AB
![]() Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
Moleculink AB
![]() Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Nexttobe AB
![]() Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
- Stock Market
- Insiders
- Bengt Ågerup